SEC Form 4 · accession 0001104659-16-095476
MARINUS PHARMACEUTICALS INC · MRNS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Enrique J. Carrazana
Director
Period of report
Feb 4, 2016
Accepted (ET)
Feb 10, 2016 · 4:01 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001267813
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock option (right to buy)F1 | $5.63 | Feb 4, 2016 | A | 25,000 | A | — | Feb 4, 2026 | Common Stock | 25,000 | 25,000 | D |
Explanation of responses
- F1Options to purchase shares vest in 12 equal monthly installments on the last day of each month commencing 02/29/2016.